How the 2002 Women's Health Initiative Changed HRT
Schwartz argues that the Women's Health Initiative used non-human-identical hormones in an older, higher-risk population and was interpreted too broadly. She says the resulting warnings caused millions of women to be taken off hormone therapy and that later reassessments received far less media attention.
- The study used hormone formulations unlike current bioidentical options
- Participants included women years past menopause with pre-existing risks
- The public message treated different hormone formulations as one class
- Later findings did not receive comparable media coverage
“It's the kind of hormones that you're taking. And it's all because of a study that went arry in 2002 called the Women's Health Initiative.”
“They were 10 years postmenopause. They were smokers. They had all kinds of pre-existing conditions.”